奥鲁卡治疗

US · ORKA #2003 按市值排名上市于 1970

71.93 -1.94 -2.63%

实时 - 追踪5344个代码 - 心跳于2秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量增加了1家。
机构持股总比例下降了9.6个百分点。

机构持股

机构持股比例: 113.10% -9.62pp
机构数量: 306 +1
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund68.12%

Hedge Fund26.64%

VC/PE Fund14.26%

Individual/Insider2.21%

Private Company1.83%

Public Company1.43%

Sovereign Wealth Fund0.39%

Government Pension Fund0.20%

Insurance Company0.15%

主要股东截至 2026-06-30

FMR 13.68% · 9.06M 股

BlackRock 7.54% · 4.99M 股

VR Management, LLC 6.27% · 4.15M 股

Fairmount Funds Management LLC 5.60% · 3.71M 股

Capital Research 5.14% · 3.40M 股

RTW Investments, LP 4.74% · 3.14M 股

Vanguard Capital Management, LLC 4.12% · 2.73M 股

State Street Global Advisors 4.04% · 2.67M 股

Paradigm Biocapital Advisors LP 3.24% · 2.14M 股

T. Rowe Price Group, Inc. 2.93% · 1.94M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 7次买入 · 43次卖出

姓名	职务	持股比例
Lawrence Klein	Chief Executive Officer	1.39%
Laura Sandler	Senior Vice President of Operations & Boston Site Head	0.36%
Larry Edwards	Chief Commercial Officer	0.15%
Cameron Turtle	Independent Director	0.13%
Carl Dambkowski	Independent Director	0.06%
Joana Goncalves	Chief Medical Officer	0.05%
Paul Quinlan	General Counsel	0.05%
Arjun Agarwal	Senior Vice President of Finance & Treasurer	0.02%
Bong Koh	--	--
Kristine Ball	Independent Director	--

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-30	Lawrence Klein	Chief Executive Officer	Derivative Exercise and Sale	-25,000	$7.80–84.78
2026-09-20	Paul Quinlan	General Counsel	Derivative Exercise and Sale	-10,000	$7.80–95.31
2026-09-20	Arjun Agarwal	Senior Vice President of Finance & Treasurer	Automatic Disposition	-533	$95.75
2026-09-14	Paul Quinlan	General Counsel	Open Market Disposition	-1,039	$95.71
2026-09-14	Joana Goncalves	Chief Medical Officer	Open Market Disposition	-947	$95.71
2026-09-14	Joana Goncalves	Chief Medical Officer	Derivative Exercise and Sale	-7,000	$6.84–94.22
2026-09-14	Lawrence Klein	Chief Executive Officer	Open Market Disposition	-2,452	$95.71
2026-09-14	Arjun Agarwal	Senior Vice President of Finance & Treasurer	Open Market Disposition	-560	$95.71
2026-09-14	Laura Sandler	Senior Vice President of Operations & Boston Site Head	Open Market Disposition	-906	$95.71
2026-09-10	Arjun Agarwal	Senior Vice President of Finance & Treasurer	Derivative Exercise and Sale	-9,459	$12.50–94.02
2026-08-31	Lawrence Klein	Chief Executive Officer	Derivative Exercise and Sale	-75,000	$7.80–92.44
2026-08-31	Laura Sandler	Senior Vice President of Operations & Boston Site Head	Derivative Exercise and Sale	-5,000	$7.80–92.01
2026-08-23	Larry Edwards	Chief Commercial Officer	Other Acquisition	+100,000	--
2026-08-23	Larry Edwards	Chief Commercial Officer	Other Derivative Acquisition	+20,000	$102.42
2026-08-16	Joana Goncalves	Chief Medical Officer	Derivative Exercise and Sale	-7,000	$6.84–112.56
2026-08-13	Paul Quinlan	General Counsel	Derivative Exercise and Sale	-52,000	$7.80–111.14
2026-08-12	Arjun Agarwal	Senior Vice President of Finance & Treasurer	Derivative Exercise and Sale	-10,000	$12.50–108.46
2026-07-14	Joana Goncalves	Chief Medical Officer	Derivative Exercise and Sale	-7,000	$6.84–87.25
2026-07-12	Arjun Agarwal	Senior Vice President of Finance & Treasurer	Derivative Exercise and Sale	-9,999	$12.50–85.63
2026-06-30	Fairmount Funds Management LLC	--	Intent to Sell (Form 144)	-3,553,410	$84.43

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。